全文获取类型
收费全文 | 196790篇 |
免费 | 2401篇 |
国内免费 | 42篇 |
专业分类
耳鼻咽喉 | 1272篇 |
儿科学 | 7321篇 |
妇产科学 | 3732篇 |
基础医学 | 19233篇 |
口腔科学 | 1832篇 |
临床医学 | 15943篇 |
内科学 | 34241篇 |
皮肤病学 | 859篇 |
神经病学 | 18716篇 |
特种医学 | 9276篇 |
外国民族医学 | 1篇 |
外科学 | 30628篇 |
综合类 | 2584篇 |
一般理论 | 33篇 |
预防医学 | 21315篇 |
眼科学 | 3051篇 |
药学 | 10767篇 |
中国医学 | 646篇 |
肿瘤学 | 17783篇 |
出版年
2023年 | 144篇 |
2022年 | 196篇 |
2021年 | 433篇 |
2020年 | 300篇 |
2019年 | 460篇 |
2018年 | 22369篇 |
2017年 | 17713篇 |
2016年 | 19897篇 |
2015年 | 1444篇 |
2014年 | 1522篇 |
2013年 | 1850篇 |
2012年 | 8506篇 |
2011年 | 22652篇 |
2010年 | 19629篇 |
2009年 | 12290篇 |
2008年 | 20923篇 |
2007年 | 23237篇 |
2006年 | 2031篇 |
2005年 | 3647篇 |
2004年 | 4855篇 |
2003年 | 5696篇 |
2002年 | 3835篇 |
2001年 | 517篇 |
2000年 | 564篇 |
1999年 | 361篇 |
1998年 | 471篇 |
1997年 | 434篇 |
1996年 | 259篇 |
1995年 | 278篇 |
1994年 | 264篇 |
1993年 | 185篇 |
1992年 | 168篇 |
1991年 | 188篇 |
1990年 | 211篇 |
1989年 | 168篇 |
1988年 | 137篇 |
1987年 | 113篇 |
1986年 | 76篇 |
1985年 | 114篇 |
1984年 | 82篇 |
1983年 | 81篇 |
1982年 | 89篇 |
1981年 | 65篇 |
1980年 | 86篇 |
1978年 | 40篇 |
1974年 | 34篇 |
1969年 | 34篇 |
1938年 | 61篇 |
1932年 | 57篇 |
1930年 | 47篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
941.
942.
Ann Taber Youngrok Park Alana Lelo Frederik Prip Jerry Xiao Deborah L. Berry Krysta Chaldekas Jørgen Bjerggaard Jensen George Philips Jung-Sik Kim Brent T. Harris Lars Dyrskjøt Todd Waldman 《Urologic oncology》2021,39(7):438.e1-438.e9
ObjectiveImprovements to bladder cancer risk stratification guidelines are needed to better tailor post-operative surveillance and adjuvant therapy to individual patients. We previously identified STAG2 as a commonly mutated tumor suppressor gene in bladder cancer and an independent predictor of progression in NMIBC. Here we test the value of combining STAG2 immunostaining with other risk stratification biomarkers in NMIBC, and as an individual biomarker in MIBC.Materials and MethodsSTAG2 immunohistochemistry was performed on a progressor-enriched cohort of tumors from 297 patients with NMIBC, and on tumors from 406 patients with MIBC from Aarhus University Hospital in Denmark. Survival analysis was performed using Kaplan-Meier survival analysis, the log rank test, and Cox proportional hazards models.ResultsSTAG2-negative low-grade NMIBC tumors were 2.5 times less likely to progress to muscle invasion than STAG2-positive low-grade NMIBC tumors (Log-rank test, P = 0.008). In a composite group of patients with AUA intermediate and high-risk NMIBC tumors, STAG2-negative tumors were less likely to progress (Log-rank test, P = 0.02). In contrast to NMIBC, we show that STAG2 is not useful as a prognostic biomarker in MIBC.ConclusionsSTAG2 immunostaining can be used to subdivide low-grade NMIBC tumors into two groups with substantially different risks of disease progression. Furthermore, STAG2 immunostaining may be useful to enhance NMIBC risk stratification guidelines, though larger cohorts are needed to solidify this conclusion in individual risk groups. STAG2 is not useful as a biomarker in MIBC. Further study of the use of STAG2 immunostaining as a biomarker for predicting the clinical behavior in NMIBC is warranted. 相似文献
943.
David P. Al-Adra Laura Hammel John Roberts E. Steve Woodle Deborah Levine Didier Mandelbrot Elizabeth Verna Jayme Locke Jonathan D'Cunha Maryjane Farr Deirdre Sawinski Piyush K. Agarwal Jennifer Plichta Sandhya Pruthi Deborah Farr Richard Carvajal John Walker Fiona Zwald Thomas Habermann Morie Gertz Philip Bierman Don S. Dizon Carrie Langstraat Talal Al-Qaoud Scott Eggener John P. Richgels George J. Chang Cristina Geltzeiler Gonzalo Sapisochin Rocco Ricciardi Alexander S. Krupnick Cassie Kennedy Nisha Mohindra David P. Foley Kymberly D. Watt 《American journal of transplantation》2021,21(2):460-474
Patients undergoing evaluation for solid organ transplantation (SOT) often have a history of malignancy. Although the cancer has been treated in these patients, the benefits of transplantation need to be balanced against the risk of tumor recurrence, especially in the setting of immunosuppression. Prior guidelines of when to transplant patients with a prior treated malignancy do not take in to account current staging, disease biology, or advances in cancer treatments. To develop contemporary recommendations, the American Society of Transplantation held a consensus workshop to perform a comprehensive review of current literature regarding cancer therapies, cancer stage-specific prognosis, the kinetics of cancer recurrence, and the limited data on the effects of immunosuppression on cancer-specific outcomes. This document contains prognosis based on contemporary treatment and transplant recommendations for breast, colorectal, anal, urological, gynecological, and nonsmall cell lung cancers. This conference and consensus documents aim to provide recommendations to assist in the evaluation of patients for SOT given a history of a pretransplant malignancy. 相似文献
944.
Tarek Alhamad Michelle Lubetzky Krista L. Lentine Emmanuel Edusei Ronald Parsons Martha Pavlakis Kenneth J. Woodside Deborah Adey Christopher D. Blosser Beatrice P. Concepcion John Friedewald Alexander Wiseman Neeraj Singh Su-Hsin Chang Gaurav Gupta Miklos Z. Molnar Arpita Basu Edward Kraus Song Ong Arman Faravardeh Ekamol Tantisattamo Leonardo Riella Jim Rice Darshana M. Dadhania 《American journal of transplantation》2021,21(9):3034-3042
Kidney allograft failure and return to dialysis carry a high risk of morbidity. A practice survey was developed by the AST Kidney Pancreas Community of Practice workgroup and distributed electronically to the AST members. There were 104 respondents who represented 92 kidney transplant centers. Most survey respondents were transplant nephrologists at academic centers. The most common approach to immunosuppression management was to withdraw the antimetabolite first (73%), while only 12% responded they would withdraw calcineurin inhibitor (CNI) first. More than 60% reported that the availability of a living donor is the most important factor in their decision to taper immunosuppression, followed by risk of infection, risk of sensitization, frailty, and side effects of medications. More than half of respondents reported that embolization was either not available or offered to less than 10% as an option for surgical intervention. Majority reported that ≤50% of failed allograft patients were re-listed before dialysis, and less than a quarter of transplant nephrologists performed frequent visits with their patients with failed kidney allograft after they return to dialysis. This survey demonstrates heterogeneity in the care of patients with a failing allograft and the need for more evidence to guide improvements in clinical practice related to transition of care. 相似文献
945.
Abdullah Al-Mitwalli Grigorios Kyriazis Omar El-Taji Elizabeth Chandra Wearmouth Deborah Phillipa Burns Youssef Fady Matthew Simms Smith Nicholas 《Current Urology》2021,15(2):115
Background:Urosepsis is a recognized complication of transrectal ultrasound-guided prostate biopsy (TRUS-Bx). Pre-biopsy rectal swabs have been used to identify patients with microorganisms in the rectal flora resistant to the conventionally used empirical prophylaxis. The transperineal route of biopsy (TP-Bx) has a lower complication risk but comes at an increased cost.Materials and methods:Retrospective cohort study including patients undergoing prostate biopsies between October/2015 and April/2018. The intervention cohort, a rectal swab was performed, the result of which dictated the biopsy route; TRUS-Bx against TP-Bx. TP-Bx for patients with fluoroquinolone resistance or extended-spectrum β-lactamase. The control cohort underwent TRUS without a rectal swab receiving empirical antibiotics—oral ciprofloxacin and intravenous gentamicin.Results:Total 1000 patients were included in which 500 underwent a swab, 14 (2.8%) developed post-TRUS biopsy infective complications with 3 having positive bacteremia (0.6%); 500 had no swab, 47 (9.4%) developed post-TRUS biopsy infective complications with 22 (4.4%, p < 0.05) having positive bacteremia. Three patients (0.6%) of patients who underwent swab developed urinary tract infection symptoms whilst 12 (2.4%) had urinary tract infection in the control group. In those patients that underwent a swab, 14 required hospitalization with mean length of stay of 2.5 days versus 43 patients of the control with 3.6 days. Cost analysis concluded savings of this strategy was £18,711.Conclusions:We have demonstrated a protocol that reserves template biopsies for higher risk patients and can significantly reduce sepsis and other infectious complication rates whilst also proving to be a cost-efficient strategy. We recommend that units not utilizing rectal swabs to uncover the fluoroquinolone resistance rate by introducing them. We advocate units that already utilize rectal swabs, to introduce transperineal biopsy for their higher risk patients. 相似文献
946.
947.
Kristin A. Maurer Laura Blue Sean Orzol Nikkilyn Morrison Hensleigh Deborah Peikes 《Health services research》2021,56(2):334
ObjectiveTo evaluate the comparability of commercially available practice site data from SK&A with survey data to understand the implications of using SK&A data for health services research.Data sourcesResponses to the Comprehensive Primary Care Plus (CPC+) Practice Survey and SK&A data.Study designComparison of CPC + Practice Survey responses to SK&A information for 2698 primary care practice sites.Data collectionCPC + Practice Survey data collected through a web‐only survey from April through September 2017, and SK&A data purchased in November 2016.Principal findingsInformation was similar across data sources, although some discrepancies were common. For example, 56% of practice sites had differences in the reported number of practitioners, and larger sites tended to have larger differences. Among practice sites with 1 practitioner in the survey, only 1.3% had a difference of 3 or more practitioners between the data sources, whereas 63% of practice sites with 11 or more practitioners had a difference of 3 or more practitioners.ConclusionsDiscrepancies between data sources could reflect differences of interpretation when defining practice site characteristics, changes over time in those characteristics, or data errors in either SK&A or the survey. Researchers using SK&A data should consider possible ramifications for their studies. 相似文献
948.
949.
Immunogenicity of fowlpox virus expressing the avian influenza virus H5 gene (TROVAC AIV-H5) in cats 总被引:4,自引:0,他引:4
Karaca K Swayne DE Grosenbaugh D Bublot M Robles A Spackman E Nordgren R 《Clinical and diagnostic laboratory immunology》2005,12(11):1340-1342
Vaccination of cats with fowlpox virus expressing the avian influenza (AI) virus H5 hemagglutinin gene (TROVAC AI) resulted in detectable hemagglutination inhibition (HI) antibody responses to the homologous A/Turkey/Ireland/1378/83 (H5N8) (A/tky/Ire/83) AI virus antigen. The HI antibody responses to heterologous A/Chicken/Indonesia/7/03 (H5N1) (A/ck/Indonesia/03) AI virus antigen were also detected in all vaccinated cats, but only after booster vaccinations. The vaccine described in this study and other poxvirus-vectored vaccines may be of value for the prophylaxis of AI virus-associated morbidity and mortality in mammals. 相似文献
950.
In many organisms completion of the first meiotic cell division depends on the correct assembly and disassembly of the synaptonemal
complex (SC). This is a structure discovered a little over 50 years ago, which is formed by the close association of axes
of homologous sister chromatid pairs. Its structure varies between organisms, although it retains a common tripartite organization
in species as evolutionarily distant as budding yeast and humans. In mammals it is essential for crossover formation and completion
of meiosis. Components of the mammalian SC have been identified only in the last 15 years, and mouse genetic approaches have
started revealing the importance for this structure only in the past 5 years. Here we discuss the progress that has been made
in the field of the mammalian SC and what approaches could be considered for its further study. 相似文献